Dr. Divya Tiwari Koura, MD

Dr. Koura practices at Scripps Green Hospital in La Jolla, California, part of Scripps Health.

Dr. Koura's NPI, 1053471318, was assigned on December 9, 2006. Dr. Koura graduated from WashU Medicine in 2006. Dr. Koura holds California license A125774.

Dr. Koura's primary practice is Scripps Green Hospital, at 10666 North Torrey Pines Road, La Jolla, CA 92037 in San Diego County. The practice phone is (858) 554-3600.

Dr. Koura's primary practice is Scripps Green Hospital in La Jolla, California, part of Scripps Health. Dr. Koura is also affiliated with Scripps Memorial Hospital La Jolla. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. Koura to 3 more hospitals, 1 breast imaging center, 1 group practice or clinic and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Koura practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Koura's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Koura is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Koura's licenses on file in 3 states: California, Georgia and Hawaii.

Dmand AI lists anemia, chronic leukemia, lymphoma, multiple myeloma, neutropenia and purpura and thrombocytopenia among the conditions Dr. Koura treats.

CMS data shows 491 Medicare services from Dr. Koura across 8 procedure codes in 2024, for 113 Medicare patients. Medicare paid $44,382 for them.

CMS counts 113 Medicare patients who saw Dr. Koura in 2024. The largest group is 65 to 74, with 57 patients. 67% of them have high blood pressure, and 55% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Koura's median patient age at 61, with 52% women.

In 2024, Dr. Koura wrote 743 Medicare Part D claims for 61 patients. 72% of them were for generic drugs. CMS names the drug for 507 of them, across 18 drugs with 11 or more claims each, at $1,756,295 in total drug cost. In 2023, CMS named 474 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Koura for performance year 2024, reported as part of a group. Dr. Koura accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Koura as offering telehealth.

Dmand AI links 20 papers to Dr. Koura, published from 2013 to 2025. 2013 was the busiest year, with 2. The most frequent topics are Hematopoietic Stem Cell Transplantation, Graft vs Host Disease and Immunosuppressive Agents. Dr. Koura has published most often in J Natl Compr Canc Netw. Dr. Koura's most frequent co-authors are Gregory A. Broderick, MD, Nazanin I. Khakpour, MD and Michelle Elizabeth Melisko, MD.

Dmand AI links Dr. Koura to 8 clinical trials, 2 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid and Anemia, Sickle Cell. National Cancer Institute (NCI) sponsors the most, 2.

CMS Open Payments shows 28 general payments to Dr. Koura from 17 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 96% of the total. Boston Scientific Corporation paid the most, $179.

Dr. Koura graduated from WashU Medicine in 2006.

Dr. Koura is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.